http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016036060-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7109d1d17db551bbb88d66bca2836069 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate | 2015-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74f9f8de127470ea91d1bbe861fe46d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3f68adeccf25e8ee28acf3402532132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9d5d7e734d1c69d40b611079688fd1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e1a2927d55175dff3f2c680c12c4189 |
| publicationDate | 2016-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2016036060-A1 |
| titleOfInvention | Novel cell membrane-penetrating peptide, and use thereof as bioactive substance carrier |
| abstract | The present invention relates to novel cell membrane-penetrating peptides capable of penetrating a cell membrane of a eukaryotic cell and delivering substances that are hard to deliver into the cell into the eukaryotic cell through various bindings, and a peptide carrier capable of penetrating a cell membrane and effectively delivering various bioactive substances into the cell, using peptides searched from a human-derived amino acid sequence. It has been confirmed that the present invention has the effect of delivering cell membrane-penetrating peptides found through search into cells by binding the peptides with a protein and a nucleic acid, and it has been confirmed that the peptides have a superior efficacy compared to an R9 peptide, which is a conventional cell-penetrating peptide. It is expected that the present invention can significantly contribute to the development and utilization of pharmaceuticals, cosmetics and functional products, etc. using a variety of bioactive substances that are hard to deliver into cells and thus could not be utilized. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109553659-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109553659-A |
| priorityDate | 2014-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 200.